Teza Capital Management’s 10x Genomics TXG Stock Holding History

Teza Capital Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-16,096	Closed	-$231K	–	592
2024 Q4	$231K	Buy	+16,096	New	+$254K	0.04%	411
2024 Q2	–	Sell	-16,351	Closed	-$614K	–	769
2024 Q1	$614K	Buy	16,351 +11,284	+223%	+$496K	0.08%	307
2023 Q4	$284K	Buy	+5,067	New	+$220K	0.05%	424
2023 Q3	–	Sell	-5,387	Closed	-$301K	–	771
2023 Q2	$301K	Sell	5,387 -2,526	-32%	-$137K	0.05%	405
2023 Q1	$441K	Buy	+7,913	New	+$370K	0.1%	296

Other funds holding TXG

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Teza Capital Management's TXG Position: Q1 2025 in Review

Teza Capital Management sold out of 10x Genomics (TXG) in Q1 2025, closing a stake of 16,096 shares — an estimated $231K sold.

Teza Capital Management first reported a position in TXG in Q1 2023 and held it in 5 quarters. The position peaked at $614K in Q1 2024. 274 funds tracked by Wall St. Rank hold TXG as of Q1 2025.

Teza Capital Management reported no remaining 10x Genomics position as of Q1 2025 after selling out during the quarter.
Teza Capital Management sold 16,096 10x Genomics shares in Q1 2025, an estimated $231K.
Teza Capital Management first reported a position in 10x Genomics in Q1 2023 and held it in 5 quarters.
Teza Capital Management's 10x Genomics position peaked at $614K in Q1 2024.
274 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2025.

Based on Teza Capital Management's 13F filing for Q1 2025, filed 15 May 2025.